Literature DB >> 34173692

Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.

Tai Joon An1, Youlim Kim2, Yong Bum Park3, Kyungjoo Kim4, Do Yeon Cho5, Kwang-Ha Yoo6, Chin Kook Rhee4.   

Abstract

Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.
© 2021 Asian Pacific Society of Respirology.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus disease; inhaled corticosteroid; prognosis

Mesh：

Substances：

Year:  2021        PMID： 34173692     DOI： 10.1111/resp.14108

Source DB:  PubMed          Journal:  Respirology        ISSN： 1323-7799            Impact factor:   6.424


  3 in total

Review 1.  Contemporary Concise Review 2021: COVID-19 and other respiratory infections.

Authors:  Ken K P Chan; David S C Hui
Journal:  Respirology       Date:  2022-06-07       Impact factor: 6.175

2.  Continuing Quality Assessment Program Improves Clinical Outcomes of Hospitalized Community-Acquired Pneumonia: A Nationwide Cross-Sectional Study in Korea.

Authors:  Tai Joon An; Jun-Pyo Myong; Yun-Hee Lee; Sang Ok Kwon; Eun Kyung Shim; Ji Hyeon Shin; Hyoung Kyu Yoon; Sung Hwan Jeong
Journal:  J Korean Med Sci       Date:  2022-08-01       Impact factor: 5.354

3.  FVC, but not FEV1, is associated with clinical outcomes of asthma-COPD overlap.

Authors:  Tai Joon An; Chin Kook Rhee; Yong Bum Park; Kwang-Ha Yoo; Hyoung Kyu Yoon
Journal:  Sci Rep       Date:  2022-08-15       Impact factor: 4.996
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.